The Complete Blood Count with Differential hematological assay is a mainstay diagnostic for point-ofcare clinical diagnoses for a spectrum of diseases including infection, inflammation, anemia, and leukemia, and CBC-D profiles are under investigation as early prognostic biomarkers for leukemias and other diseases. Chronic abdominal pain (CAP) and irritable bowel syndrome (IBS) are prevalent gastrointestinal disorders in the United States, with obesity among the most common comorbidities. Often, IBS-like gastrointestinal (GI) symptoms persist after resolution of known inflammation and/or enteropathogenic infection, and current literature contains significant discussion of the extent to which IBS is within the biological spectrum of inflammatory disease. Obesity is also associated with generalized signatures of inflammation and may confound accurate diagnoses. We performed ANOVA, multiple means comparisons, statistical analyses of CBC data from our "Brain-Gut Natural History" (BGNH) clinical cohort, with additional ELISA assays for lipopolysaccharide binding protein (LBP), IL-10, cortisol, and ACTH, signatures of immune-inflammatory response and Hypothalamic-Pituitary-Adrenal (HPA) axis activity, respectively. BGNH cohort includes healthy and overweight individuals diagnosed with IBS diarrhea-(IBS-D) and constipation-predominant (IBS-C) subtypes. We identified several potentially significant markers for IBS-D and IBS-C, notably IL-10, mean platelet volume (MPV), with LBP and monocyte percent also showing some statistical significance. Weight also showed significant results for overweight vs. normal weight, regardless of IBS subtype, particularly for Cortisol. CBC-D predictive profiles for IBS subtype and weight were identified using discriminant functions analysis and show that predictivity of marker profiles have poor performance relative to their normal weight subsets. Further refinement of this analysis will be performed utilizing increased sample size, additional molecular profiles, and enhanced statistical analysis.
Glossary of Abbreviations

Introduction
Chronic abdominal pain (CAP) and irritable bowel syndrome (IBS), with diarrhea-(IBS-D) and constipation-predominant (IBS-C) subtypes, are among the most common gastrointestinal disorders in Western nations, however identification of mechanistic associations have proven difficult given the heterogeneity of possible underlying mechanisms [1] [2] [3] [4] . Gastrointestinal pain and diarrhea are also symptoms of enteropathogenic infection and inflammatory bowel disease (IBD). Significant discussion appears in recent literature that IBS (or a proportion of IBS cases) may represent a mild, subclinical extreme of the IBD 'spectrum', which many authors have supported and provided evidence for [5] [6] [7] [8] [9] . Complete blood count with differential (CBC-D) hematological test is the routine multiparameter test providing clinicians with identification of hematological perturbation and infectious immune responses [10] . CBC-D has recently been the focus of discovery of prognostic biomarkers in diseases including Tcell lymphoma [11] , peripheral arterial disease [12] , and many others.
MVP, ESR, and CRP parameters of CBC-D have each been reported as statistically-supported indicators of IBD. [13, 14] CBC monocyte count is also indicator of inflammation [15] . CD14, LPS, Cortisol, and IL-10 are reported indicators of immune response or inflammatory suppression, respectively. sCD14 is an indicator of monocyte activation [16] , and both sCD14 and LPS are play roles in innate immunity via interactions with the TLR4 receptor [17] . IL-10 is an important anti-inflammatory cytokine associated with IBD [18, 19] , with significant application as anti-inflammatory therapeutic compound.
[20] Regulation of macrophage activity by IL-10 appears particularly important in intestinal inflammation. IL-10 is produced by macrophages in response to LPS exposure [21] . IL-10 activates its own expression in macrophages via Stat3 transcription factor [22] . Mutations in IL-10 or IL-10 receptors (IL-10R) result in uncontrolled inflammation, and absence of IL-10R results in spontaneous inflammation. [23, 24] IL-10 exposure results in differentiation of inflammation-regulatory macrophage subtypes. [25, 26] IL-10 also affects T-cell activity in colitis. [27, 28] 
Methods
Clinical Protocol (NCT00824941)
Participants in this study gave informed consent at the National Institutes of Health's Hatfield Clinical Research Center under our IRB-approved "Brain-Gut Interactions in Overweight and Normal Weight Patients with Chronic Abdominal Pain" (09-NR-0064) natural history clinical protocol. Participants must be between the ages of 13-45 years, and, if female, have regular menstrual cycles. Participants were evaluated for CAP using the Gastrointestinal Pain Pointer (GIPP) tool [29] , and were diagnosed for IBS and IBS-subtype under the Rome III Criteria, [2] with subtypes classified as diarrhea-predominant IBS (IBS-D) and constipation-predominant IBS (IBS-C). The participants diagnosed with mixed-type IBS (IBS-M) or un-subtyped IBS (IBS-U) were excluded from this analysis due to small sample size. Participants were classified by body mass index (BMI) into "normal" (BMI < 25) and "overweight" (BMI ≥ 25) groups. Measurements of height and weight (duplicate) were averaged to calculate patients' BMI. Table 1A shows summary statistics for the cohort's phenotypic distribution.
Complete Blood Count with Differential (CBC-D)
In the protocol's clinical visits, fasting blood was collected in the morning from participants. Standard blood panels are submitted to NIH-CRC Department of Laboratory Medicine (DLM) for CBC-D, serum cortisol and ACTH. The full matrix used in this study is found in Sup. Data 1, summarized in Table 1A .
CBC-D data was compiled and curated from the NIH CRC Biomedical Translational Research Information System (BTRIS) [30] and Clinical Research Information System (CRIS) databases (https://cris.cc.nih.gov/index.html). CBC data provides absolute counts by volume for overall WBCs, and absolute and relative counts for monocytes, lymphocytes, neutrophils, and eosinophils. WBC differential counts were compiled including absolute counts and relative abundance of each cell category. Absolute counts (x10 6 cells/mL) for overall WBCs, neutrophils, monocytes, lymphocytes, basophils, and eosinophils and relative abundance (percentage of overall WBC count) for neutrophils, monocytes, lymphocytes, basophils, and eosinophils were evaluated. Serum immunoglobulin tests were also analyzed for IgA, IgG, IgM, and IgE. Other CBC-D data collected for each participant included MPV, MCH, HCT, ESR, LDH, serum cortisol, ACTH, CRP, platelet counts, and red blood cell counts.
ELISA quantification of serum protein biomarkers
Research blood was collected for concurrent processing of serum and plasma using standard laboratory protocols.
ELISAs were performed according to the manufacturer's instructions for IL-10 (Quantikine®HS ELISA Human IL-10 Immunoassay, R&D Systems, Inc., Cat# HS100B), sCD14 (Quantikine® ELISA Human sCD14 Immunoassay, R&D Systems, Inc., Cat# DC140), I-FABP (Human I-FABP ELISA Kit, Hycult biotech, Cat# HK406), and LBP (Human Lipopolysaccharide Binding Protein ELISA Kit, Cell Sciences, Inc., Cat# CKH113).
Stool culture tests
Stool culture tests for enteropathogenic microbes are a standard diagnostic for enteropathogenic infection in the intestine, which also produce diarrheal and chronic pain symptomology. [31] In our cohort, diagnostic testing was performed using enteric bacterial culture, ova and parasite exam, anti- Box-and-Whisker plots for multiple comparisons were produced with R package ggplot2. P-values are reported for 1-tailed t-tests on multiple means comparisons that showed statistically significant results (Fig. 1, Table 1B ).
Discriminant Functions Analysis
Discriminant functions analysis is a multivariate, supervised grouping method (a generalization of Fischer's linear discriminant) used to predict categorical classification variables based on multiple continuous variables. [33] Data were subset into normal and overweight groups, and discriminant analysis was used on each subset using JMP13.
[34] Complete results including canonical plots are provided (Sup. Data 4 (normal weight subset), Sup. 5 (overweight subset)).
Results and Discussion
CBC and serum ELISA panels demonstrate a signature of immune/inflammatory suppression associated with the IBS-D/Normal Weight cohort subset. (Table 1B , Fig. 1A-C, Fig. 2A ,B,C, Sup. Data 1-3). Significant IBS-D associated increases in MPV, LBP, cortisol, and IL-10 are observed, suggesting innate immune activation and inflammatory response (represented by increased LBP and MPV, respectively) with a corresponding signature of immunosuppressive response (cortisol, IL-10) (Fig. 1A,B , Table 1B ). Increased MPV is associated with inflammatory disorders, including IBD [13, 14] . IL-10 is a key inflammatory suppression cytokine associated with IBD and is an important developmental switch in monocyte -> macrophage differentiation, acting through the Stat3 transcription factor, its known effector [22, [24] [25] [26] . IL-10 itself is produced by Monocytes, regulatory B-cells and other immune cells in response to LPS [21] . In our data, IBS-D is associated with a weakly significant decrease in Monocyte percentage based on the CBC-D test, while absolute Monocyte counts, contrary to current IBD literature have been reported be increased [15] .
This pattern, observed in our IBS-D/Normal Weight cohort subset, is consistent with a suppressed immune/inflammatory response. Stool culture testing was performed on a subset of our cohort, however positive stool culture results were not significantly correlated with IBS symptoms; in fact, in many cases, IBS subjects had negative stool cultures, while Healthy Controls showed positive results (Sup. Data 1). Many researchers have supported the possibility that IBS is representative of a 'low-grade inflammation' along a spectrum of inflammatory disease [6] [7] [8] [9] . Individuals with resolved enteropathogenic infection or IBD in remission often report persistent visceral hypersensitivity with IBSlike symptomology (diarrhea or constipation) [35] [36] [37] .
CBC and serum ELISA panels identify overweight-associated effect across IBS-subtypes, and additional inflammatory signatures in IBS-C/overweight subsets. (Table 1B , and is an IBD marker of anemia in its own right [38] . Given these results, IBS-C appears to have less significant associations than IBS-D, with perturbations often associated with weight, rather than with the IBS-C subtype.
Obesity and Metabolic Syndrome are especially common co-morbidities for GI disorders, and often cooccur with IBS symptomology [39] , and with elevated pain phenotypes in general [40] . Inflammation is associated with obesity, as well as with associated perturbations of the gut microbiota [41, 42] . Overweight subsets from our Healthy Control/Overweight and IBS-C/Overweight subsets are associated with elevated CRP and ESR, both of which are standard diagnostic markers for inflammation associated with IBD [43, 44] . In our cohort, we find CRP and ESR elevation more associated with Healthy Control/Overweight and IBS-C/Overweight than with IBS symptomology, and these may therefore be indicative of inflammatory signature of weight-associated inflammation rather than of IBS-associated inflammation.
Monocytes and other immune cells exhibit small but significant perturbations in relative abundance based on CBC data. (Table 1B , Fig. 2 ). Monocyte percent is significantly decreased in CBC-based statistical comparisons between IBS-D vs. HC cohort subsets (Table 1B , Supplementary Data), although these are still within the clinical "normal range" of ~400-1000 cells/ul, or 2-10% of the relative WBC count.
Observations from CBC-D support a suppression of monocyte abundance in the PBMC population associated with IBS-D and overweight phenotypes. Neutrophils are shown as having a decreased relative abundance in the expression assay but have insignificant CBC results.
Additional small yet significant changes are seen in immune cell count and immunoglobulin counts associated with IBS subtype and weight subsets. Changes in percentage counts from CBC for Macrophage, Neutrophil, Lymphocyte, and Eosinophils appear variously associated with IBS-D and IBS-C (Table 1, Fig. 2 ). While significant, most of individual perturbations are within the normal diagnostic ranges for their respective counts.
Discriminant functions analysis of CBC data shows diminished predictivity for IBS subtype in OW compared with NW subsets. (Fig. 1D, Supplementary Data 4,5) . We tested predictivity of multivariate parameter profiles, subsetting the cohort by weight (normal and overweight) and applied discriminant functions analysis to a multivariate profile of significantly affected variables. Confirming statistical results described above, predictivity (a function of the multi-parameter eigenvalue derivative) was good for IBS-D and IBS-C individuals from the normal weight subset, with good separation of IBS-subtypes encompassed within the first canonical coordinate. However, predictivity was poorer between IBS subtypes in the overweight subset, with small distances and overlapping predictions within canonical coordinates 1 and 2. This confirms predictivity for IBS-D with the variable set is significantly degraded in the overweight cohort participants.
Conclusion
In IBS-D, previous research demonstrated an association with signatures of immune/inflammatory responses, with significant discussion in the literature as to what extent IBS symptoms fall along the continuum of IBD. [45] Here we report perturbation of many parameters associated with IBS-D which have also been reported associated with IBD, including the anti-inflammatory cytokine IL-10 and modulation of monocyte/macrophage activation [18, 19, 21-23, 25, 26, 46-48] .
We observe small but significant perturbations associated with IBS subtype and weight corresponding with many previously reported signatures of inflammation and innate immune activation. Weight plays a significant role as a covariate in each of the separate data-type comparisons and is particularly significant in obscuring the diagnostic value of CBC parameters. Analysis of much larger cohorts, and inclusion of additional genetic, medical history, and psychological data has been a successful approach [49] . 
